Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What is the anticipated market size of the medical needle free injection industry over the next few years?
The medical needle-free injection market size has grown rapidly in recent years. It will grow from $14.36 billion in 2024 to $16.25 billion in 2025 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to increasing demand for painless drug delivery, rise in self-administration of medications, growing preference for minimally invasive procedures, increasing adoption of home healthcare solutions and rising demand for needle-free alternatives.
The medical needle-free injection market size is expected to see rapid growth in the next few years. It will grow to $26.33 billion in 2029 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing technological advancements in drug delivery systems, rising demand for personalized medicine, growing focus on patient comfort and convenience, expansion of the biologics and biosimilars market, and increasing healthcare expenditures in emerging economies. Major trends in the forecast period include advancement in jet injection technology, development of more compact and portable devices, innovation in combination drug delivery systems, advancement in microneedle technology for painless injections, and development of multi-dose needle-free injectors.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24304&type=smp
What emerging drivers are expected to shape the future of the medical needle free injection market?
The increasing number of diabetes patients is expected to propel the growth of the medical needle-free injection market going forward. Diabetes is a chronic medical condition where the body cannot properly regulate blood sugar or glucose levels. The growing prevalence of diabetes is mainly driven by rising obesity rates, which increase the likelihood of developing type 2 diabetes. Medical needle-free injections offer diabetes patients a painless, non-intimidating way to administer insulin or other medications through high-pressure technology. This approach reduces discomfort, alleviates needle anxiety, and enhances patient adherence to treatment. For instance, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. Therefore, the increasing number of diabetes patients is driving the growth of the medical needle-free injection market.
What emerging segments are shaping the future landscape of the medical needle free injection industry?
The medical needle free injection market covered in this report is segmented –
1) By Product Type: Jet-Based Needle Free Injectors, Spring-Based Needle Free Injectors, Laser-Powered Needle Free Injectors, Vibration-Based Needle Free Injectors
2) By Mode Of Delivery: Subcutaneous Delivery, Intramuscular Delivery, Intradermal (ID) Delivery, Intravenous (IV) Delivery
3) By Application: Vaccine Delivery, Insulin Delivery, Pain Management, Oncology, Other Applications
4) By End-User: Hospitals, Clinics, Home Care Settings, Research Laboratories, Other End-Users
Subsegments:
1) By Jet-Based Needle Free Injectors: High-Pressure Jet Injectors, Disposable Jet Injectors, Multi-Use Nozzle Jet Injectors, Gas-Powered Jet Injectors, Electronically Controlled Jet Injectors
2) By Spring-Based Needle Free Injectors: Manual Spring-Loaded Injectors, Auto-Spring-Loaded Injectors, Single-Dose Spring Injectors, Reusable Spring Injectors
3) By Laser-Powered Needle Free Injectors: Infrared Laser-Based Injectors, Ultraviolet Laser-Based Injectors, Pulsed Laser Systems, Continuous Wave Laser Systems
4) By Vibration-Based Needle Free Injectors: Ultrasonic Vibration Injectors, Piezoelectric-Based Injectors, Electromagnetic Vibration Injectors, Micro-Vibration-Assisted Delivery Systems
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/medical-needle-free-injection-global-market-report
What are the top market trends driving innovation in the medical needle free injection industry?
Major companies operating in the medical needle-free injection market are focusing on developing advanced products, such as jet-based needle-free injection systems to enhance drug delivery efficiency and reduce patient discomfort. Jet-based needle-free injection systems utilize high-pressure liquid streams to administer medication without needles, offering a safer and pain-free alternative to traditional methods. For instance, in November 2024, Sol-Millennium Medical Group, a US-based manufacturer of medical devices, launched the InsuJet, a needle-free insulin injection device, in Canada. It utilizes high-pressure jet technology to deliver insulin without needles, aiming to reduce discomfort, anxiety, and needle-related risks while improving treatment adherence.
How are key players in the medical needle free injection market strengthening their market position?
Major companies operating in the medical needle free injection market are Pfizer Inc., Medline Industries LP., Daicel Corporation, AptarGroup Inc., Gerresheimer AG, Portal Instruments, Inovio Pharmaceuticals Inc., PharmaJet Inc., RPK Group, National Medical Products Inc., Mika Medical, Injex Pharma AG, Crossject SA, InsuJet, NuGen Medical Devices Inc., Robbins Instruments, PICOCYL, MIT Canada Inc., AcuShot Needle Free, FlowBeams
Which geographic areas are contributing significantly to the growth of the medical needle free injection sector?
North America was the largest region in the medical needle free injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical needle free injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Medical Needle Free Injection Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/customise?id=24304&type=smp
Need Customized Data On Medical Needle Free Injection Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24304&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
